Toggle navigation
Home
Search
Services
Blog
Contact
About
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael
Corporate Software, Inc., Arlington, VA, United States
Search 7 grants from Michael Rubenstein
Search grants from Corporate Software, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Intranasal Stem-Cell Based Therapy for Glioblastoma
Heart Failure Adherence and Retention Trial (HART)
The Connectimmunity Project
G1 Progression in Budding Yeast
Regulation of Catecholamine Receptors
Recently added grants:
Functional evaluation of a new GWAS locus that links visceral adiposity and type 2 diabetes
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
The impact of obesity on cerebral glucose transport and metabolism
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Library of Medicine (NLM)
Type
Research and Development Contracts (N01)
Project #
N01LM043537-000
Application #
3664656
Study Section
Project Start
1994-08-25
Project End
Budget Start
1994-08-25
Budget End
1995-08-24
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Corporate Software, Inc.
Department
Type
DUNS #
City
Arlington
State
VA
Country
United States
Zip Code
22209
Related projects
NIH 1995
N01 LM
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael / Corporate Software, Inc.
NIH 1994
N01 LM
Z3950 Implementation Corporate Software Inc
Rubenstein, Michael / Corporate Software, Inc.
Comments
Be the first to comment on Michael Rubenstein's grant